Abstract
Predictive testing for adult- and child-onset diseases is becoming widely available. The identification of individuals prone to develop certain illnesses is often medically advantageous in that it may afford opportunities to engage in risk reduction behaviors to detect or delay disease onset. However, sometimes the knowledge gained from these tests can be ambiguous, generate distress, and potentially affect several generations of family members. Overall, these factors create a challenging set of circumstances for persons considering genetic and other forms of predictive testing, particularly parents and children. In this article, we (1) address conceptual issues involved in determining the impact of predictive testing on child and family well-being, (2) review empirical data on this topic, and (3) provide a case example to illustrate these findings. Recommendations are made for additional psychological research on child- and family-focused outcomes associated with participation in testing, highlighting their clinical implications.
Similar content being viewed by others
REFERENCES
American Society of Clinical Oncology (ASCO). (1996). Statement of the American Society of Clinical Oncology: Genetic testing for cancer susceptibility. Journal of Clinical Oncology, 141730-1736.
American Society of Human Genetics Board of Directors and American College of Medical Genetics Board of Directors (ASHG/ACMG). (1995). Points to consider: Ethical, legal, and psychosocial implications of genetic testing in children and adolescents. American Journal of Human Genetics, 571233-1241.
Anderson, C. A., & Hammen, C. L. (1993). Psychosocial outcomes of children of unipolar depressed, bipolar, medically ill, and normal women: A longitudinal study. Journal of Consulting and Clinical Psychology, 61, 448-454.
Armistead, L., Klein, K., & Forehand, R. (1995). Parental physical illness and child functioning. Clinical Psychology Review, 15409-422.
Armistead, L., Klein, K., Forehand, R., & Wierson, M. (1997). Disclosure of parental HIV infection to children in the families of men with hemophilia: Description, outcomes, and the role of family process. Journal of Family Psychology, 11, 49-61.
Ballenger, J., & Alpert, J. J. (1989). Family factors in the decision to seek medical care. In C. N. Ramsey (Ed.), Family systems in medicine(pp. 407-415). New York: Guilford.
Baum, A., Friedman, A. L., & Zakowski, S. G. (1997). Stress and genetic testing for disease risk. Health Psychology, 16, 8-19.
Benkendorf, J. L., Reutenauer, J. E., Hughes, C. A., Eads, N., Willison, J., Powers, M., & Lerman, C. (1997). Patients' attitudes about autonomy and confidentiality in genetic testing for breast-ovarian cancer susceptibility. American Journal of Medical Genetics, 73, 296-303.
Bibace, R., & Walsh, M. E. (1980). Development of children's concepts of illness. Pediatrics, 66, 912-917.
Biesecker, B. B., Boehnke, M., Calzone, K.,Markel, D. S., Garber, J. E., Collins, F. S., & Weber, B. L. (1993). Genetic counseling for families with inherited susceptibility to breast and ovarian cancer. JAMA, 269, 1970-1974.
Bloch, M., Adam, S., Wiggins, S., Huggins, M., & Hayden, M. R. (1992). Predictive testing for Huntington disease in Canada: The experience of those receiving an increased risk. American Journal of Medical Genetics, 42, 499-507.
Botkin, J. R., Croyle, R. T., Smith, K. R., Baty, B. J., Lerman, C., Goldgar, D. E.,Ward, J. M., Flick, B. J., & Nash, J. E. (1996). Amodel protocol for evaluating the behavioral and psychosocial effects of BRCA1 testing. Journal National Cancer Institute, 88872-882.
Bronfrenbrenner, U. (1979). The ecology of human development.Cambridge, MA: Harvard University Press.
Burbach, D. J., & Peterson, L. (1986). Children's concepts of physical illness: A review and critique of the cognitive-developmental literature. Health Psychology, 5, 307-325.
Burke, W., Daly, M., Barber, J., Botkin, J., Kahn, M. J. E., Lynch, P., McTiernan, A., Offit, K., Perlman, J., Petersen, G., Thomson, E., & Varricchio, C. (1997). Recommendations for followup care of individuals with an inherited predisposition to cancer II: BRCA1 and BRCA2. JAMA, 277, 997-1003.
Cho, M. K., Sankar, P., Wolpe, P. R., & Godmilow, L. (1999). Commercialization of BRCA1/2 testing: Practitioner awareness and use of a new genetic test. American Journal of Medical Genetics, 83, 157-163.
Collins, F. S. (1999). Shattuck lecture—Medical and societal consequences of the Human Genome Project. NewEngland Journal of Medicine, 341, 28-37.
Compas, B. E. (1998). An agenda for coping research and theory: Basic and applied developmental issues. International Journal of Behavioral Development, 22, 231-237.
Compas, B. E., Worsham, N. L., Epping-Jordan, J. E., Grant, K. E., Mireault, G., Howell, D. C., & Malcarne, V. L. (1994). When mom or dad has cancer: Markers of psychological distress in cancer patients, spouses, and children. Health Psychology, 13507-515.
Codori, A., Petersen, G. M., Boyd, P. A., Brandt, J., & Giardiello, F. M. (1996). Genetic testing for cancer in children: Short-term psychological effect. Archives of Pediatrics and Adolescent Medicine, 150, 1131-1138.
Craufurd, D., Dodge, A., Kerzin-Storrar, L., & Harris R. (1989). Uptake of presymptomatic predictive testing for Huntington's disease. Lancet, 2, 603-605.
Croyle, R. T., & Lerman, C. (in press). Risk communication in genetic testing for cancer susceptibility. Journal of the National Cancer Institute.
Daly, M., Farmer, J., Harrop-Stein, C., Montgomery, S., Itzen, M., Costalas, J. W., Rogatko, A., Miller, S., Balshem, A., & Gillespie, D. (1999). Exploring family relationships in cancer risk counseling using the genogram. Cancer Epidemiology, Biomarkers, and Prevention, 8, 393-398.
Fanos, J. H. (1996). Sibling loss.Mahwah, NJ: Erlbaum.
Fanos, J. H. (1997). Developmental tasks of childhood and adolescence: Implications for genetic testing. American Journal of Medical Genetics, 71, 22-28.
Fanos, J. H., & Gatti, R. A. (1999). A mark on the arm: Myths of carrier status in sibs of individuals with ataxia-telangiectasia. American Journal of Medical Genetics, 86, 338-346.
Finney, J. W., & Miller, K. M. (1999). Children of parents with medical illness. In W. K. Silverman & T. H. Ollendick (Eds.), Developmental issues in the clinical treatment of children(pp. 433-442). Boston: Allyn & Bacon.
Frank, T. S., Manley, S. A., Olopade, O. I., Cummings, S., Garber, J. E., Bernhardt, B., Antman, K., Russo, D., Wood, M. E., Mullineau, L., Isaacs, C., Peshkin, B., Buys, S., Venne, V., Rowley, P. T., Loader, S., Offit, K., Robson, M., Hampel, H., Brener, D., Winer, E. P., Clark, S., Weber, B., Strong, L. C., Rieger, P., McClure, M., Ward, B. E., Shattuck-Eidens, D., Oliphant, A., Skolnick, M. H., & Thomas A. (1998). Sequence analysis of BRCA1 and BRCA2: Correlation of mutations with family history and ovarian cancer risk. Journal of Clinical Oncology, 16, 2417-2425.
GeneTests. (Accessed 4/9/99). Available Internet: www.genetests.org.
Glasgow, R. E., Fisher, E. B., and erson, B. J., LaGreca, A., Marrero, D., Johnson, S. B., Rubin, R. R., & Cox, D. J. (1999). Behavioral science in diabetes: Contributions and opportunities. Diabetes Care, 22, 832-843.
Goldenberg, I., & Goldenberg, H. (1991). Family therapy: An overview(3rd ed.). Pacific Grove, CA: Brooks/Cole.
Grosfeld, F. J., Lips, C. J., Beemer, F. A., van Spijker, H. G., Brouwers-Smalbraak, G. J., & ten Kroode, H. F. (1997). Psychological risks of genetically testing children for a hereditary cancer syndrome. Patient Education and Counseling, 3263-67.
Harper, P. S., & Clarke, A. (1990). Should we test children for ‘adult’ genetic diseases? Lancet, 335, 1205-1206.
Hilton B. A., & Elfert, H. (1996). Children's experiences with mothers' early breast cancer. Cancer Practice, 4, 96-104.
Hoffman, L. (1981). Foundations of family therapy: A conceptual framework for systems change.New York: Basic Books.
Howes, M. J., Hoke, L., Winterbottom,M., & Delafield, D. (1994). Psychosocial effects of breast cancer on the patient's children. Journal of Psychosocial Oncology, 12, 1-21.
Hughes, C., Lynch, H., Durham, C., Snyder, C., Lemon, S., Narod, S., Fulmore, C., Main, D., & Lerman, C. (1999). Communication of BRCA1/2 test results in hereditary breast cancer families. Cancer Research, Therapy and Control, 8, 51-59.
Israel, M. A. (1989). Pediatric oncology: Model tumors of unparalleled import. Journal of the National Cancer Institute, 81404-408.
Jacobsen, P. B., Valdimarsdottir, H. B., Brown, K. L., & Offitt, K. (1997). Decision-making about genetic testing among women at familial risk for breast cancer. Psychosomatic Medicine, 59459-466.
Johnson, S. B., Riley, W. J., Hansen, C. A., & Nurick, M. A. (1990). Psychological impact of islet cell-antibody screening: Preliminary results. Diabetes Care, 13, 93-97.
Johnson, S. B., & Tercyak, K. P. (1995). Psychological impact of islet cell antibody screening for IDDM on children, adults and their family members. Diabetes Care, 18, 1370-1372.
Kazak, A. E. (1989). Families of chronically ill children: A systems and social-ecological model of adaptation to challenge. Journal of Consulting and Clinical Psychology, 57, 25-30.
Kazak, A. E., & Simms, S. (1996). Children and life-threatening illnesses: Psychological difficulties and interpersonal relationships. In F. Kaslow (Ed.), Handbook of relational diagnosis and dysfunctional family patterns(pp. 225-238). New York: Wiley.
Knip, M. (1998). Prediction and prevention of type 1 diabetes. Acta Paediatrica Supplement, 425, 54-62.
Knudson, A. G. (1993). Pediatric molecular oncology: Past as prologue to the future. Cancer, 71, 3320-3324.
Lerman, C., Daly, M.,Masny, A., & Balshem, A. (1994). Attitudes about genetic testing for breast-ovarian cancer susceptibility. Journal of Clinical Oncology, 12, 843-850.
Lerman, C., Narod, S., Schulman, K., Hughes, C., Gomez-Caminero, A., Bonney, G., Gold, K., Trock, B., Main, D., Lynch, J., Fulmore, C., Snyder, C., Lemon, S. J., Conway, T., Tonin, P., Lenoir, G., & Lynch, H. (1996). BRCA1 testing in families with hereditary breast-ovarian cancer: A prospective study of patient decision-making and outcomes. JAMA, 275, 1885-1892.
Lerman, C., Peshkin, B. N., Hughes, C., & Isaacs, C. (1998). Family disclosure in genetic testing for cancer susceptibility: Determinants and consequences. Journal of Health Care Law and Policy, 1, 353-372.
Lucidarme, N., Domingues-Muriel, E., Castro, D., Czernichow, P., & Levy-Marchal, C. (1998). Appraisal and implications of predictive testing for insulin-dependent diabetes mellitus. Diabetes and Metabolism, 24, 550-553.
Lynch, H. T., & Lynch, J. F. (1998). Genetics of colonic cancer. Digestion, 59, 481-492.
Markel, D. S., Young, A. B., & Penney, J. B. (1987). At-risk 68 Tercyak, Streisand, Peshkin, and Lerman persons' attitudes toward presymptomatic and prenatal testing of Huntington disease in Michigan. American Journal of Medical Genetics, 26, 295-305.
Marteau, T. M. (1994). The genetic testing of children. Journal of Medical Genetics, 31, 743.
McNeil, T. F., Harty, B., Thelin, T., Aspegren-Jansson, E., & Sveger, T. (1986). Identifying children at high somatic risk: Long-term effects on mother-child interaction. Acta Psychiatrica Scandinavica, 74, 555-562.
McNeil, T. F., Thelin, T., Aspegren-Jansson, E., & Sveger, T. (1985a). Identifying children at high somatic risk: Possible effects on the parents' views of the child's health and parents' relationship to the pediatric health services. Acta Psychiatrica Scandinavica, 72, 491-497.
McNeil, T. F., Thelin, T., Aspegren-Jansson, E., & Sveger, T. (1985b). Identifying children at high somatic risk: Possible long-term effects on parental conceptualizations of the child's personality and behavior. Acta Psychiatrica Scandinavica, 72498-504.
McNeil, T. F., Thelin, T., Aspegren-Jansson, E., & Sveger, T. (1986). Identifying children at high somatic risk: Possible longterm effects on the parents' relationship to the child. Acta Psychiatrica Scandinavica, 74, 347-352.
Michie, S., & Marteau, T. M. (1996). Predictive genetic testing in children: The need for psychological research. British Journal of Health Psychology, 1, 3-14.
Michie, S., McDonald, V., & Marteau, T. (1996). Understanding responses to predictive genetic testing: A grounded theory approach. Psychology and Health, 11, 455-470.
Narod, S. A., Risch, H., Moslehi, R., Dorum, A., Neuhausen, S., Olsson, H., Provencher, D., Radice, P., Evans, G., Bishop, S., Brunet, J. S., & Ponder, B. A. J. (1998). Oral contraceptives and the risk of hereditary ovarian cancer. New England Journal of Medicine, 339, 424-428.
National Advisory Council for Human Genome Research. (1994). Statement on use of DNA testing for presymptomatic identification of cancer risk. JAMA, 271, 785.
Nichols, K. E., Li, F. P., Haber, D. A., & Diller, L. (1998). Childhood cancer predisposition: Applications of molecular testing and future implications. Journal of Pediatrics, 132, 389-397.
O'Connor, T. G., Hetherington, E. M., & Reiss, D. Family systems and adolescent development: Shared and nonshared risk and protective factors in nondivorced and remarried families. Developmental Psychopathology, 10, 353-375.
Olson, D. H. (1989). Circumplex model of family systems VIII: Family assessment and intervention. In D. H. Olson, C. S. Russell, & D. H. Sprenkle (Eds.), Circumplex model: Systemic assessment and treatment of families(pp. 7-49). New York: Haworth.
Patenaude, A. F. (1996). The genetic testing of children for cancer susceptibility: Ethical, legal, and social issues. Behavioral Sciences and the Law, 14, 393-410.
Patenaude, A. F., Basili, L., Fairclough, D. L., & Li, F. P. (1996). Attitudes of 47 mothers of pediatric oncology patients toward genetic testing for cancer predisposition. Journal of Clinical Oncology, 14, 415-421.
Petersen, G. M., & Brensinger, J. D. (1996). Genetic testing and counseling in familial adenomatous polyposis. Oncology, 1089-94.
Ponder, M., & Green, J. M. (1996). BRCA1 testing: Some issues in moving from research to service. Psycho-oncology, 5223-232.
Quaid, K. A., & Morris, M. (1993). Reluctance to undergo predictive testing: The case of Huntington disease. American Journal of Medical Genetics, 45, 41-45.
Rimer, B. K., Sugarman, J., Winer, E., Bluman, L. G., & Lerman, C. (1998). Informed consent for BRCA1 and BRCA2 testing. Breast Disease, 10, 99-114.
Rolland, J. (1994). Families, illness, and disability: An integrative treatment model.New York: Basic Books.
Rolland, J. S. (1999). Families and genetic fate: A millennial challenge. Families, Systems, and Health, 17, 123-132.
Schaefer, C., Coyne, J. C., & Lazarus, R. S. (1981). The healthrelated functions of social support. Journal of Behavioral Medicine, 4381-406.
Strong, L. C., & Marteau, T. (1995). Evaluating children and adolescents for heritable cancer risk. Journal of the National Cancer Institute Monographs, 17, 111-113.
Tercyak, K. P., Johnson, S. B., & Schatz, D. A. (1998). Patient and family perceptions of the use of subcutaneous insulin to prevent IDDM: Implications for current and future prevention trials. Journal of Diabetes and its Complications, 12279-286.
Tercyak, K. P., Lerman, C., Hughes, C., & Main, D. (1999). Parental communication ofBRCA1/2 genetic test results to children [Abstract]. Annals of Behavioral Medicine, 21, 94.
Thelin, T., McNeil, T. F., Aspegren-Jansson, E., & Sveger, T. (1985a). Identifying children at high somatic risk: Parents' long-term emotional adjustment to their children's alpha 1 antitrypsin deficiency. Acta Psychiatrica Scandinavica, 72323-330.
Thelin, T., McNeil, T. F., Aspegren-Jansson, E., & Sveger, T. (1985b). Identifying children at high somatic risk: Possible long-term effects on the parents' views of the own health and current life situation. Acta Psychiatrica Scandinavica, 71644-653.
Ursin, G., Henderson, B. E., Haile, R. W., Pike, M. C., Zhou, N., Diep, A., & Bernstein, L. (1997). Does oral contraceptive use increase the risk of breast cancer in women with BRCA1/ BRCA2 mutations more than in other women? Cancer Research, 573678-3681.
Weber, B., & Roth, R. (1997). Psychological aspects in diabetes prevention trials. Annals of Medicine, 29, 461-467
Welch, A. S., Wadsworth, M. E., & Compas, B. E. (1996). Adjustment of children and adolescents to parental cancer. Cancer, 771409-1418.
Wertz, D. C., Fanos, J. H., & Reilly, P. R. (1994). Genetic testing for children and adolescents: Who decides? JAMA, 272, 875-881.
Wiener, L. S., Battles, H. B., & Heilman, N. E. (1998). Factors associated with parents' decision to disclose their HIV diagnosis to their children. Child Welfare, 77, 115-135.
Wiener, L. S., Battles, H. B., Heilman, N., Sigelman, C. K., & Pizzo, P. A. (1996). Factors associated with disclosure of diagnosis to children with HIV/AIDS. Pediatric AIDS and HIV Infection: Fetus to Adolescent, 7, 310-324.
Worsham, N. L., Compas, B. E., & Ey, S. (1997). Children's coping with parental illness. In S. A. Wolchik & I. N. Sandler (Eds.), Handbook of children's coping: Linking theory and intervention(pp. 195-213). New York: Plenum.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tercyak, K.P., Streisand, R., Peshkin, B.N. et al. Psychosocial Impact of Predictive Testing for Illness on Children and Families: Challenges for a New Millennium. Journal of Clinical Psychology in Medical Settings 7, 55–68 (2000). https://doi.org/10.1023/A:1009597303743
Issue Date:
DOI: https://doi.org/10.1023/A:1009597303743